These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date and reported results||2005-000664-51||A RANDOMIZED DOUBLE-BLIND PARALLELL GROUP CLINICAL STUDY OF XENETIX 300 VERSUS VISIPAQUE 270 IN MULTISLICE CT PEDIATRIC INDICATIONS||2009-04-24||bad-data|
|Reported results||2006-001298-57||Comparison of the diagnostic efficacy of Xenetix 350 and Iomeron 400, for visualisation of the aorta and abdominal vascular tree with 64-slices computed tomography||2008-02-28||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2007-000229-23||EVALUACIÓN DE LA SEGURIDAD RENAL TRAS ARM POTENCIADA CON DOTAREM EN COMPARACIÓN CON LA RM SIN CONTRASTE ENTRE PACIENTES CON ALTO RIESGO DE PADECER NEFROPATIA PROVOCADA POR EL MEDIO DE CONTRASTE||2011-05-09||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2009-010968-42||Efficacy evaluation of DOTAREM®-enhanced MRA compared to GADOVIST®–enhanced MRA in the diagnosis of clinically significant abdominal or lower limb arterial diseases||2012-01-07||bad-data|
|Reported results||2009-011002-42||Intra-individual efficacy evaluation of DOTAREM®-enhanced MRA compared to GADOVIST®–enhanced MRA in the diagnosis of clinically significant abdominal or limb arterial diseases||2010-07-12||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2010-020319-34||Evaluación de la seguridad y la eficacia de Dotarem en resonancia magnética (RM) en pacientes con lesiones del sistema nervioso central (SNC) SAFETY AND EFFICACY EVALUATION OF DOTAREM® IN MAGNETIC RE...||2011-11-16||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2010-021826-37||Xenetix 350: comparative assesment of Image quality for coronary CT Angiography.||2012-09-17||bad-data|
|Reported results||2011-002609-31||Diagnostic contribution of XENETIX® CT PERFUSION in pre-therapeutical assessment of hepatocellular carcinoma.||2015-12-18||due-trials|
|Reported results||2013-003215-21||DOTAREM® Pharmacokinetics, Safety and Efficacy Study in Pediatric||2015-10-19||due-trials|
|Completed, report not yet due||2014-003576-23||P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)||2018-01-23||not-yet-due|
|Ongoing||2016-002930-62||Proof of Concept study concerning efficacy of P03277 MR Imaging in HCC diagnosis Phase IIa Clinical Study||not-yet-due|
|No trial status on register||2018-001516-30||Pharmacokinetics, safety and efficacy of a new gadolinium-based contrast agent, P03277, in pediatric patients from 2 to 17 years of age undergoing central nervous system contrast-enhanced MRI.||bad-data|